New pill shows promise for slowing Parkinson's progression
NCT ID NCT06596005
First seen Sep 30, 2025 · Last updated May 23, 2026 · Updated 25 times
Summary
This study tested a new drug called TJ0113 in 149 people with early-stage Parkinson's disease. Half received the drug and half received a placebo (a dummy pill) for 12 weeks. The main goal was to see if TJ0113 improved motor symptoms (like movement and coordination) compared to placebo. The trial is complete, and results will show if the drug is safe and effective for early Parkinson's.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Second Affiliated Hospital, School of Medicine, Zhejiang University, China
Hangzhou, Zhejiang, 310009, China
Conditions
Explore the condition pages connected to this study.